June 15, 2020

ProSciento, Clinical Research Organization (CRO) Focused on Metabolic Diseases, Institutes Rapid COVID-19 Antigen and Antibody Testing at Clinical Research Unit in Southern California Read More »

February 11, 2020

ProSciento Appoints Dr. Michael Grimm as Chief Medical Officer Read More »

ProSciento - Top Work Places


View Our Presentation


May 4, 2020

Clinical Research Considerations for Biosimilar Insulins Read More »

May 1, 2020

Specialized Expertise to Drive Advances in Diabetes Drug and Device Development Read More »

December 14, 2019

Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption Read More »

Learn about ProSciento services for COVID-19 clinical studies in healthy subjects